Skip to main content

The Globe and Mail

Canopy Growth Corp (WEED-T) Quote

Unchecking box will stop auto data updates
TSX Real-Time Last Sale CAD
Today's Change
Price Quote as of

Today's Trading

Day Low 19.66
Day High 20.19
Price movement based on the high, low and last over the given period.
Previous Close
Average Volume
Price/Earnings (TTM)
Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Canopy Growth Corp through its subsidiaries is the licensed producer of medical marijuana in Canada. The company grows, produces and sells medical marijuana. It sells medical marijuana under various brand names including Tweed, Bedrocan, and Mettrum.


Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share ttm
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings ttm
Annual Dividend & Yield
Ex-Div Date
Forward P/E
Most Recent Split


Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

The Therapeutic Potential of Pharmacologically Active Cannabinoids
PR Newswire - Tue Dec 12, 7:30AM CST
PR Newswire - CMTX
Tue Dec 12, 7:30AM CST
The discovery of the human body's endocannabinoid system in the early 1990s led to a surge of new drug development activity to address multiple maladies and identify new ways to treat serious diseases. The pharma industry's predominant focus has been on the most recognized and easiest-to-isolate plant-sourced cannabinoids THC (tetrahydrocannabinol) and CBD (cannabidiol). Despite their potential therapeutic efficacy, plant-sourced cannabinoid therapies have complex development limitations that impede effective use. Beyond economic constraints on production, inherent problems exist in ensuring the quality, purity and consistency requisite for serious pharmaceutical drug development. But InMed Pharmaceuticals, Inc. (CSE: IN) (OTC: IMLFF) (IMLFF Profile) has initiated a scientific paradigm shift in discovering potential breakthrough cannabinoid-based therapies that advances far beyond basic cannabinoid production and the over-the-counter sales of oils and elixirs. The company's proprietary biosynthesis process sets it apart from the operations of companies like Isodiol International, Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F), as well as from other biotechs and growers in the cannabis industry who rely on the supply of leading cultivators like Canopy Growth Corp. (TSX: WEED) (OTC: TWMJF), Aurora Cannabis, Inc. (TSX: ACB) (OTC: ACBFF) and Aphria, Inc. (TSX: APH) (OTC: APHQF).
Alternate Health's Investor Webcast And Presentation Now Available For On-Demand Viewing At
PR Newswire - Mon Dec 11, 7:35AM CST
PR Newswire - CMTX
Mon Dec 11, 7:35AM CST
Alternate Health Corp ("Alternate Health" or the "Company") (CSE:AHG) (OTCQB:AHGIF), an international, vertically-integrated medical cannabis company, today announced that the Dec. 7th investor presentation and webcast from Alternate Health CEO Dr. Michael Murphy is now available for on-demand viewing at
Newfoundland & Labrador and Canopy Growth Enter Comprehensive Supply, Development and Retail Agreement
Canada Newswire - Fri Dec 8, 7:12AM CST
Canada Newswire - CMTX
Fri Dec 8, 7:12AM CST
ST. JOHN'S & SMITHS FALLS, ON, Dec. 8, 2017 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") along with representatives from the Province of Newfoundland and Labrador today are pleased to announce that the Company has entered into a supply and production agreement, the largest provincial cannabis supply agreement announced to date, securing a regulated supply of cannabis for Newfoundlanders and Labradorians heading into the legal adult access market.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 16.62 +20.28% increase
on 11/16/17
Period Open:19.98
Price movement based on the high, low and last over the given period.
20.75 -3.66% decrease
on 11/13/17
+0.01 (+0.05%) increase
since 11/10/17
3-Month 9.83 +103.36% increase
on 09/14/17
Period Open:10.10
Price movement based on the high, low and last over the given period.
21.72 -7.97% decrease
on 11/07/17
+9.89 (+97.92%) increase
since 09/12/17
52-Week 6.58 +203.80% increase
on 06/07/17
Period Open:10.00
Price movement based on the high, low and last over the given period.
21.72 -7.97% decrease
on 11/07/17
+9.99 (+99.90%) increase
since 12/12/16

All market data is provided by Barchart Solutions (will open in new tab). Copyright © 2017.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

More stories below advertisement